Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Pipeline

RNA therapeutics for complex diseases

At Nutcracker Therapeutics, we are driven by the unique opportunity that RNA offers to develop best-in-class medicines that will improve human health around the world. Because the promise of RNA isn’t the future, it’s now.

Pipeline

Program

Program

Discovery

Lead candidate identification

IND-enabling studies

Phases 1-3

NTX-250

Target

Undisclosed

Modality

Multimodal RNA therapeutic

Indication

HPV-driven tumors
Discovery Lead candidate identification IND-enabling studies Phases 1-3

NTX-565

Target

Undisclosed

Modality

Patient-specific multimodal RNA therapeutic

Indication

T cell lymphoma
Discovery Lead candidate identification IND-enabling studies Phases 1-3

NTX-470

Target

Undisclosed

Modality

Multimodal RNA therapeutic

Indication

Genitourinary tumors
Discovery Lead candidate identification IND-enabling studies Phases 1-3